5 Key Takeaways
-
1
Cytiva's FlexFactory showcased at CPHI Frankfurt 202
-
2
Focus on agile and modular biomanufacturing.
-
3
Shift towards personalized therapies including mRNA.
-
4
Comprehensive lifecycle support from facility design to training.
-
5
Aims to reduce complexity in biomanufacturing processes.
At CPHI Frankfurt 2025, Cytiva showcased its KUBio box trailer featuring the FlexFactory manufacturing solution, reflecting the industry's transition to personalized therapies like mRNA and gene therapies. Joe Wakowiecki, Cytiva's Enterprise Solutions Director, emphasizes the trend towards smaller, agile manufacturing environments that prioritize flexibility. Cytiva provides extensive biomanufacturing support, covering all aspects from facility design to operator training, enabling clients to concentrate on scientific endeavors while Cytiva handles infrastructure complexities.
Listen Tab content